Efficacy and toxicity of compassionate ibrutinib use in relapsed/refractory chronic lymphocytic leukemia in Poland: analysis of the Polish Adult Leukemia Group (PALG)Elżbieta Iskierka‐Jazdzewska, Krzysztof Jamroziak, Magdalena Piotrowska et al.|Leukemia & lymphoma/Leukemia and lymphoma|2017Cited by 39
Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignanciesMatthew S. Davids, Ian W. Flinn, Owen A. O’Connor et al.|Blood Advances|2021Cited by 21
Primary and Secondary Central Nervous System Involvement in Acute Myeloid LeukemiaJoanna Góra‐Tybor, Andrzej Szczepaniak, Marta Barańska et al.|Journal of Leukemia|2019Cited by 9